SNARE proteins direct membrane fusion events required for platelet granule secretion. These proteins are oriented in cell membranes such that the majority of the protein resides in a cytosolic compartment.
Introduction
Platelets represent an unusual model for studying membrane trafficking and regulated exocytosis. They are anucleate cells that are shed from maturing megakaryocytes. They acquire α-granules and dense granules via regulated delivery of pre-formed organelles to developing proplatelet ends. 1 Although receptor-mediated 2, 3 and pinocytotic 4 endocytosis have been observed in platelets, constitutive coupled endocytosis-exocytosis cycles that occur in nucleated cells in general [5] [6] [7] [8] and hematopoietic cells in particular 9 have not been documented in platelets.
Another distinctive characteristic of the platelet is that its limiting membrane is characterized by a system of tunneling invaginations of the plasma membrane termed the open canalicular system (OCS). 10, 11 Evidence that the OCS is open to the extracellular environment is derived from reports using cell-impermeant tracers. 12 The SNARE proteins that direct membrane fusion events leading to platelet granule release have been studied. 13 The tSNAREs SNAP-23 [14] [15] [16] and syntaxin-2, 4, and 7 [14] [15] [16] [17] are found in platelets.
Platelets also contain gene products of the VAMP family of vSNAREs 14 including VAMP-3 and VAMP-8, 18, 19 which participate in platelet granule secretion. 14, 19, 20 Antibodies directed at syntaxin-2 and 4 inhibit granule secretion from permeabilized platelets. 14, 16, 21 Anti-SNAP-23
antibody and a SNAP-23 blocking peptide also inhibit granule secretion. 16, 21 These functional data provide compelling evidence that SNARE proteins are essential in mediating the membrane fusion events involved in the secretion of platelet granules.
Unlike many membrane-associated proteins, SNARE proteins lack a signal sequence required for cotranslational insertion into membranes of the endoplasmic reticulum. 22, 23 Rather, membrane
For personal use only. on October 31, 2017 . by guest www.bloodjournal.org From insertion occurs post-translationally. The targeting of SNARE proteins to their respective intracellular compartments differs between individual SNARE proteins. SNAP-23 and its homologue SNAP-25 lack a membrane-spanning domain. Association of SNAP-25 with membranes requires a membrane-targeting module, located between the two α-helices, that participates directly in SNARE protein complex formation. 24 Association of SNAP-23 and SNAP-25 with membranes may also be facilitated by palmitoylation of the membrane-targeting module 25 and/or by association with syntaxin isoforms. 26 Syntaxins are tail-anchored (type IV) membrane-binding proteins that contain a carboxy-terminal hydrophobic domain inserted into the lipid bilayer. 27, 28 Syntaxin-2 localization is dictated in part but not exclusively by this carboxy-terminal transmembrane domain. [27] [28] [29] VAMP also contains a carboxy-terminal hydrophobic domain and inserts into membranes of the endoplasmic reticulum in an ATPdependent manner following translation. 23 The actual mechanisms whereby these tail-anchored SNARE proteins become correctly oriented within membranes and sorted to specific subcellular compartments have not been determined in detail.
We have previously studied the subcellular distribution of three SNARE proteins in resting platelets. 30 These studies showed that VAMP-3 is found primarily on platelet granule membranes. The majority of SNAP-23 is located on plasma membranes with the rest distributed between membranes of the OCS and granular membranes. Syntaxin-2 is more equally distributed among the different membrane compartments. This arrangement of SNARE proteins provides a molecular basis for secretion of α-granules via the plasma membrane and OCS as well as for homotypic α-granule secretion. To further evaluate the contribution of SNARE protein distribution to platelet granule secretion, we assessed the subcellular localization of
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These studies show the localization of SNARE proteins following platelet activation and represent the first demonstration of SNARE proteins on an extracellular plasma membrane surface.
Material and Methods
Approval was obtained from the Beth Israel Deaconess Medical Center institutional review board, Boston, MA for these studies. Informed consent was provided according to the Declaration of Helsinki. Digitonin and α-toxin were obtained from Calbiochem (San Diego, CA). Transfected E.coli expressing His-tagged recombinant APT1 was kindly provided by Dr. Thomas Michel. 31, 32 All solutions were prepared using water purified by reverse-phase osmosis on a Millipore Milli-Q Purification Water System.
Antibodies. Anti-SNAP-23 antibody was developed by immunizing rabbits with a peptide corresponding to the C-terminus of SNAP-23 (DRIDIANARAKKLIDS). Antibody was purified that is directed against a 19 amino acid portion towards the C-terminus of the cytoplasmic domain of syntaxin 1A. The antibody reacts with syntaxin 1A, 1B, 2, and 3. Of these syntaxin isoforms, only syntaxin-2 is found in platelets. 16 The antibody does not react with syntaxin 4 or 7. A second anti-syntaxin-2 antibody directed against a 19 amino acid portion of the N-terminus of rat syntaxin-2 from Calbiochem (San Diego, CA) was used for immunoblot analyses. Anti-VAMP-3 antibody was generated by immunizing with a peptide consisting of the 12 N-terminal amino acids of VAMP-3. 18, 30 Phycoerythrin (PE)-conjugated mouse monoclonal anti-P-selectin antibody AC1.2 was purchased from Becton Dickinson (San Jose, CA).
Platelet Preparation.
Blood from healthy donors who had not ingested aspirin in the two weeks prior to donation was collected by venipuncture into 0.4% sodium citrate. Citrate-anticoagulated blood was centrifuged at 200 x g for 20 min to prepare platelet-rich plasma. Platelet-rich plasma was then used for ultrastructural studies as described below. For platelet secretion studies, platelets were purified from platelet-rich plasma by gel-filtration using a Sepharose 2B column equilibrated in PIPES/EGTA buffer. 14, 30 Final gel-filtered platelet concentrations were 1-2 x 10 8 platelets/ml. Immunonanogold labeling for electron microscopy. Purified human platelets were incubated with buffer, 100 µM SFLLRN, or 0.2 µM PMA as indicated in the figure legend, fixed in 4% paraformaldehyde, and prepared for sectioning as previously described. 30, 33 Immunonanogold staining and processing for electron microscopy was performed at room temperature on cryostat sections mounted on glass slides as described previously except for the following modifications.
Glass slides with cryostat sections were incubated in primary polyclonal rabbit antibody directed Enzymatic treatment of resting platelets. For enzymatic treatments, gel-filtered platelets were incubated with 20 µM indomethacin in order to pacify the platelets. For trypsin digestion of platelet surface proteins, platelets (0.5 ml; 2 x 10 9 platelets/ml) were exposed to 5 µg/ml trypsin for 4 hours at 37 o C. Following this incubation, platelets were incubated with an inhibitor cocktail. Inhibition of trypsin was verified using S-2238 chromogenic substrate from Chromogenix (Milano, Italy). Following verification of trypsin inhibition, platelets were evaluated by flow cytometry. For assessing release of SNAP-23 by APT1, the enzyme was first incubated with 2 µM DTT to augment acyl-thioesterase activity. 31 Pacified, intact platelets (1 ml; 2 x 10 9 platelets/ml) were incubated in the presence or absence of 10 µg/ml APT1 for 2 hours at 30 o C. For evaluating release of syntaxin-2 by botulinum toxin C light chain, pacified concentrated platelets (1 ml; 2 x 10 9 platelets/ml) were incubated in the presence or absence of 5 µg/ml botulinum toxin C light chain overnight at 37 o C. For both preparations, platelet suspensions were pelleted at 100,000 x g for 2 hours in order to remove microparticles.
Supernatants were lyophilized, resuspended in 100 µl sample buffer and evaluated for SNAP-23 or syntaxin-2 by immunoblotting. For all studies, adequacy of pacification by indomethacin was assessed by monitoring 14 C-serotonin release 33 following incubation with trypsin or by monitoring P-selectin surface expression 14, 35, 36 following incubation with either APT1 or botulinum toxin C light chain. Platelet membrane integrity was evaluated following each enzymatic treatment by testing for permeation to sulforhodamine into platelets by flow cytometry.
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Immunofluorescence microscopy. Platelets (0.5-1 x 10 8 /ml) treated with indomethacin were exposed to buffer alone or 100 µM SFLLRN and subsequently incubated with buffer alone or 5 µg/ml trypsin for 4 hours at 37 o C. Platelets were then labeled using anti-SNAP-23 or antisyntaxin-2 antibodies, washed in PBS, stained with FITC-labeled goat anti-rabbit secondary antibodies, and washed again in PBS. Platelets were subsequently plated on polylysine-coated glass slides and visualized using an Olympus AX70 Provis microscope with a 60x 1.4-numerical aperture oil immersion lense. Digital images were captured using a Roper CoolSNAP HQ CCD camera in a 1392 x 1040 format.
Immunoprecipitation. Supernatants were prepared by centrifugation at 100,000 x g for 2 hours
from concentrated gel-filtered platelets (1 ml; 2 x 10 9 platelets/ml) incubated overnight in the presence of 10 µg/ml APT1 and 5 µg/ml botulinum toxin C light chain. Supernatants were 
Results

Localization of SNARE proteins following platelet activation
Initial studies were directed at evaluating the localization of the SNARE proteins SNAP-23, syntaxin-2, and VAMP-3 following platelet activation. Platelets were exposed to either buffer alone, a thrombin receptor activating peptide, SFLLRN, which acts through protease-activated receptor-1 (PAR1), or phorbol 12-myristate 13-acetate (PMA) to elicit activation. For localization, a pre-embedding technique using immunonanogold was employed since this technique preserves fine ultrastructural detail without compromising antigen labeling. 30, 34 Labeling of resting platelets with antibody directed at SNAP-23 demonstrated that approximately half of the label was localized to the plasma membrane and the remaining label was distributed between membranes of the OCS and granule membranes (Fig. 1A) . These results were consistent with a previously published report of SNAP-23 localization in platelets. on the plasma membrane increased (Fig. 2B ). In addition, more label appeared on the extracellular side of the plasma membrane (Fig. 2B, arrows) . Localization of syntaxin-2 to the extracellular surface was also visualized in platelets exposed to PMA (Fig. 2C, arrows) .
Quantification showed that 89.8% and 95% of platelets exposed to SFLLRN and PMA, respectively, demonstrated syntaxin-2 on their extracellular surface. Control samples processed with either substitution of irrelevant goat IgG for immune primary antibody or omission of immune primary antibody, secondary antibody, or HQ silver enhancement solution demonstrated no significant staining (data not shown). These results suggest localization of syntaxin-2 to the extracellular surface of platelets.
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From VAMP-3 has previously been found to localize primarily to granule membranes in resting platelets. 30 Immunonanogold staining of platelets exposed to buffer alone demonstrated staining of platelet granules without significant staining of platelet plasma membranes (Fig. 3A) . In platelets activated with SFLLRN, the majority of VAMP-3 remained associated with intracellular membranes (Fig. 3B) . Expression of VAMP-3 on the extracellular surface was not significant. Similarly, the majority of VAMP-3 remained associated with granule membranes following activation of platelets with PMA, without significant extracellular localization of VAMP-3 ( (Table I) .
Binding of anti-tSNARE antibodies increased substantially in both intact and stimulated platelets permeabilized with digitonin, with binding in stimulated platelets increased more than 9-fold compared to that of non-immune controls. These data demonstrate that although a detectable percentage of these tSNAREs are present on the platelet extracellular surface, the majority of SNAP-23 and syntaxin-2 are intracellular even following platelet activation.
To further verify the extracellular surface localization of SNARE proteins, we determined whether binding of anti-SNAP-23 and anti-syntaxin-2 antibodies to intact platelets is sensitive to trypsin exposure. Platelets were stimulated with either SFLLRN or PMA and then exposed to Figs. 1 and 2 ). To evaluate whether these SNARE proteins reside on the extracellular surface of resting platelets, we exposed resting platelets to trypsin prior to activation. Since trypsin could cleave these SNARE proteins regardless of whether or not their antigenic epitopes were blocked, we reasoned that trypsinization of resting platelets would decrease SNAP-23 and syntaxin-2 exposure following activation only if there was significant expression of these SNARE proteins on the surface of resting platelets. Although trypsin exposure itself activated untreated platelets as indicated by dense granule release, platelets incubated with 20 µM indomethacin remained resting following exposure to trypsin (Fig. 6A) . Evaluation of membrane integrity using sulforhodamine 37 demonstrated that trypsin exposure did not render the platelet membrane permeable (Fig. 6B ). Following incubation with resting platelets, trypsin was neutralized using a protease inhibitor cocktail and neutralization confirmed using the chromogenic substrate S-2238. Platelets were then exposed to PMA and evaluated for SNAP-23 and syntaxin-2 by flow cytometry and immunoblot analysis. Trypsinization of pacified, resting platelets inhibited detection of either SNAP-23 or syntaxin-2 following stimulation with PMA (Fig. 6C) . In contrast, stimulation of trypsinized platelets with PMA resulted in a 16.8+4.8-fold increase in P-selectin surface expression, indicating that platelets remained responsive to PMA.
Immunofluorescence microscopy was performed to further assess whether trypsin-sensitive SNAP-23 and syntaxin-2 resides on the surface of resting platelets. Indomethacin-treated platelets were exposed to either buffer alone or SFLLRN and then incubated in the presence or absence of trypsin. Intact platelets were then stained with anti-SNAP-23 or anti-syntaxin-2 antibodies, plated on polylysine-coated glass slides, and visualized by immunofluorescence microscopy. Staining of activated platelets was markedly brighter than staining of resting platelets (Fig. 6D) . However, staining of resting platelets with anti-SNAP-23 or anti-syntaxin-2 antibody was significantly greater than that with non-immune antibody, increased 3.2+0.7-fold for SNAP-23 (based on quantification of 3762 platelets) and 2.1+0.6-fold for syntaxin-2 (based on quantification of 1353 platelets). These data support the supposition that a population of SNAP-23 and syntaxin-2 is exposed on the extracellular surface of resting platelets.
Complex formation between extracellular SNAP-23 and syntaxin-2
To further evaluate the possibility that SNAP-23 and syntaxin-2 are located on the extracellular surface of resting platelets, we used enzymes to interfere with their ability to associate with (Fig. 7B) . Botulinum toxin C light chain is the catalytic subunit of botulinum toxin C, which acts by specifically cleaving certain syntaxin isoforms including syntaxin-2. 45 Botulinum toxin C light chain cleaves syntaxin-2 near the C terminus removing the transmembrane domain and allowing syntaxin-2 to dissociate from the membrane. Incubation with botulinum toxin C neither activated platelets (data not shown) nor compromised membrane integrity (Fig. 7A) . A syntaxin-2 cleavage product was observed following immunoblot analysis of pacified, resting platelets incubated with botulinum toxin C light chain (Supplemental Figure   S2 ). This cleavage product was subsequently isolated from supernatants of botulinum toxin C light chain-treated platelets (Fig. 7B) . These results provide independent confirmation that SNAP-23 and syntaxin-2 are present on the surface of resting platelets.
SNAP-23 and syntaxin isoforms are capable of forming binary complexes. 46 Furthermore, interactions of SNAP-23 and syntaxins are thought to influence the trafficking of these SNARE proteins during protein sorting. 47 We therefore sought to determine whether extracellular SNAP-23 and syntaxin-2 form a complex. We exposed platelets to APT1 and botulinum toxin C light chain, pelleted platelets and microparticles, and immunoprecipitated SNAP-23 or cleaved syntaxin-2 from supernatants. Immunopreciptation of SNAP-23 or syntaxin-2 was detected by immunoblot analysis (Fig. 7C) . 
Discussion
We have used pre-embedding immunonanogold staining to evaluate SNARE protein localization prior to and following platelet stimulation. This technique enables preservation of platelet ultrastructure, providing clear demarcation of membrane boundaries and demonstrating many of the hallmarks of platelet activation including pseudopod formation and degranulation.
Stimulation of platelets with either SFLLRN or PMA resulted in increased plasma membrane localization of SNAP-23 and syntaxin-2 ( Fig. 1 and 2 ). The observation that immunonanogold staining showed SNAP-23 and syntaxin-2 localized to the platelet surface was an unexpected finding that required confirmation using alternative strategies. immunofluorescence microscopy ( Fig. 6 ), providing further evidence that a population of these proteins resides on the extracellular surface. More specific enzymatic treatments using APT1
and botulinum toxin C also resulted in loss of SNAP-23 and syntaxin-2 from intact platelets (Fig.   7 ). Comparing staining of intact, SFLLRN-activated platelets to that of digitonin-permeabilized platelets, suggests that nearly 20% of SNAP-23 and syntaxin-2 are localized to the plasma membrane. To our knowledge this is the first report to demonstrate the presence of SNARE proteins on the extracellular surface of a cell.
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From How do platelet SNAP-23 and syntaxin-2 localize to the platelet surface? The marked increase in staining of surface SNAP-23 and syntaxin-2 by both immunonanogold localization and flow cytometry initially suggested to us that the phenomenon is activation-dependent. One possibility is that a population of SNAP-23 and syntaxin-2 is sequestered in platelet granules and exposed following activation-induced granule release. This mechanism of activation-dependent antigen exposure is observed with several platelet proteins including P-selectin and CD63. 49 ,50 Yet neither P-selectin nor CD63 are found on the surface of resting platelets. In contrast, immunonanogold localization and immunofluorescence microscopy showed SNAP-23 and syntaxin-2 on the resting platelet surface. In addition, we were not able to detect SNAP-23 or syntaxin-2 in the granules of resting platelets. Furthermore, a population of SNAP-23 and syntaxin-2 was released from resting, intact platelets following exposure to APT1 or botulinum toxin C light chain, respectively. SNAP-23 and syntaxin-2 on the extracellular surface of resting, intact platelets was also susceptible to cleavage by trypsin. These observations are inconsistent with the supposition that SNAP-23 and syntaxin-2 translocate from intracellular platelet stores to the extracellular surface only upon activation.
Another potential explanation for the presence of SNAP-23 and syntaxin-2 on the platelet surface is that these proteins traverse the plasma membrane. Certain amino acid sequences termed protein transduction domains have been described to engender peptides and proteins with the ability to cross lipid bilayers, 51-57 albeit with relatively low efficiency. 58 Of note, syntaxin-2 possesses a potential protein transduction motif in its linker domain (amino acids 141-150) and a second adjacent to its transmembrane domain (amino acids 251-264). Palmitoylation has also been used to confer peptides with the ability to cross lipid bilayers. [59] [60] [61] This domain directs membrane targeting of SNAP-25 and is itself fusogenic. 41 Whether protein transduction domains or a palmitoylated membrane binding domain endow syntaxin-2 or SNAP-23, respectively, with the ability to traverse a lipid bilayer has not been evaluated.
A third possibility is that a population of SNAP-23 and syntaxin-2 is sorted to an extracytoplasmic compartment during protein trafficking in megakaryocytes. Syntaxin isoforms are type IV integral membrane proteins that are targeted to membranes following translation rather than co-translationally. Their intracellular trafficking is directed by both their cytoplasmic and C-terminal transmembrane domains. [27] [28] [29] 62 However, the targeting of type IV integral membrane proteins is not directed by a particular consensus sequence and relatively little is known about the determinants of membrane orientation of syntaxin isoforms. Similarly, relatively little is known about the membrane interactions of SNAP-23 that occur during protein trafficking. Association of SNAP-25 and syntaxin isoforms in the endoplasmic reticulum and
Golgi of nucleated cells has been demonstrated and this association alters the membrane trafficking of both proteins. 47, 63 It is possible that a population of SNAP-23 and syntaxin-2 form a complex following translation that is preferentially trafficked to an extracytosolic compartment, while unassociated or chaperone-associated counterparts (e.g., Munc-18 isoformassociated syntaxins) are trafficked to intracellular compartments. SNAP-23 and sytnaxin-2 released from intact platelets by exposure to APT1 and botulinum toxin C light chain were coimmunoprecipitated by either anti-SNAP-23 or anti-syntaxin-2 antibodies (Fig. 7) . One Relatively few microscopy studies have been performed with adequate resolution to identify extracytosolic orientation of these membrane-associated proteins. Alternatively, the unique mechanism of platelet formation raises the possibility that localization of SNARE proteins to the extracellular surface is a platelet-specific phenomenon that could be exploited to enhance our understanding of membrane dynamics during platelet formation. Values are reported as percent of control compared to signal observed in samples exposed to nonimmune antibodies. and/or 5 µg/ml botulinum toxin C light chain, platelets were incubated in the presence or absence of the indicated enzymes, subsequently exposed to either buffer alone (black) or α-toxin (white) to permeabilize platelets, and incubated with sulforhodamine. Error bars represent the standard deviation of 3 independent experiments. B) Gel-filtered platelets were incubated with 20 µM indomethacin and subsequently exposed to either buffer alone, 10 µg/ml APT1, or 5 µg/ml botulinum toxin C light chain as indicated. Platelets were subsequently pelleted at 100,000 x g for 2 hour and supernatants were evaluated for SNAP-23 or syntaxin-2 by immunoblot analysis. C) Gel-filtered platelets were incubated with both APT1 and botulinum toxin C light chain and then pelleted.
SNAP-23 and syntaxin-2 were immunoprecipitated from supernatants.
Immunoprecipitates were then analyzed for SNAP-23 and syntaxin-2 by immunoblot analysis. 
